A Review on Banned Drugs

Authors

  • Ghodake Vaishnavi S Shivlingeshwar College of Pharmacy, Almala Dist. Latur -413520 Maharashtra (MH), India
  • Hangargekar Sachin Shivlingeshwar College of Pharmacy, Almala Dist. Latur -413520 Maharashtra (MH), India
  • Yelkote Priyanka D Shivlingeshwar College of Pharmacy, Almala Dist. Latur -413520 Maharashtra (MH), India
  • Gurav Mohini A Shivlingeshwar College of Pharmacy, Almala Dist. Latur -413520 Maharashtra (MH), India
  • Siddique Ayesha N Shivlingeshwar College of Pharmacy, Almala Dist. Latur -413520 Maharashtra (MH), India
  • Honrao Madhav Shivlingeshwar College of Pharmacy, Almala Dist. Latur -413520 Maharashtra (MH), India
  • Rohini Sante Shivlingeshwar College of Pharmacy, Almala Dist. Latur -413520 Maharashtra (MH), India
  • Phulari Madhuri. Shivlingeshwar College of Pharmacy, Almala Dist. Latur -413520 Maharashtra (MH), India

DOI:

https://doi.org/10.22270/ajprd.v11i6.1331

Keywords:

Nimesulide, Novalgin, Adverse Drug Reaction, Banned Drugs, Post Marketing Surveillance.

Abstract

India has become a hub for the availability and usage of banned or harmful medicines such as Nimesulide, D’cold, Novalgin, Lomofen, and Rofecoxib, among others. The decision to ban a drug is based on the risk versus benefit ratio evaluated through post-marketing surveillance and the Adverse Drug Reaction Reporting System. Pharmaceutical negligence among doctors can lead to hazardous effects on the general health of a patient. It is important for the government to spread information on drugsideeffects. The prescribing of drugs is an essential practice for medical professionals. In promoting a healthy lifestyle, the prevention of diseases is important, but equally important is treatment of such diseases with safe drugs. Every drug has some side effects, but with the correct dosage, it can be avoided. Banned drugs have more adverse/side effects. Drugs that are found unsafe in post-marketing surveillance are banned by regulatory authorities. The Drug Controller General of India (DCGI) is the highest authority in India to approve or ban a drug. Despite this, banned drugs are still available in developing countries such as India due to a lack of law enforcement, physician awareness, and drug control authorities failing to inform hospitals of the status of medicine. India is a major hub for banned drugs.

 

Downloads

Download data is not yet available.

Author Biographies

Ghodake Vaishnavi S, Shivlingeshwar College of Pharmacy, Almala Dist. Latur -413520 Maharashtra (MH), India

Shivlingeshwar College of Pharmacy, Almala Dist. Latur -413520 Maharashtra (MH), India

Hangargekar Sachin, Shivlingeshwar College of Pharmacy, Almala Dist. Latur -413520 Maharashtra (MH), India

Shivlingeshwar College of Pharmacy, Almala Dist. Latur -413520 Maharashtra (MH), India

Yelkote Priyanka D, Shivlingeshwar College of Pharmacy, Almala Dist. Latur -413520 Maharashtra (MH), India

Shivlingeshwar College of Pharmacy, Almala Dist. Latur -413520 Maharashtra (MH), India

Gurav Mohini A, Shivlingeshwar College of Pharmacy, Almala Dist. Latur -413520 Maharashtra (MH), India

Shivlingeshwar College of Pharmacy, Almala Dist. Latur -413520 Maharashtra (MH), India

Siddique Ayesha N, Shivlingeshwar College of Pharmacy, Almala Dist. Latur -413520 Maharashtra (MH), India

Shivlingeshwar College of Pharmacy, Almala Dist. Latur -413520 Maharashtra (MH), India

Honrao Madhav, Shivlingeshwar College of Pharmacy, Almala Dist. Latur -413520 Maharashtra (MH), India

Shivlingeshwar College of Pharmacy, Almala Dist. Latur -413520 Maharashtra (MH), India

Rohini Sante, Shivlingeshwar College of Pharmacy, Almala Dist. Latur -413520 Maharashtra (MH), India

Shivlingeshwar College of Pharmacy, Almala Dist. Latur -413520 Maharashtra (MH), India

Phulari Madhuri., Shivlingeshwar College of Pharmacy, Almala Dist. Latur -413520 Maharashtra (MH), India

Shivlingeshwar College of Pharmacy, Almala Dist. Latur -413520 Maharashtra (MH), India

References

1. https://ajpsonline.com/HTML Paper.aspx? Journal = Asian % 20 Journal % 20 of % 20 Research % 20in % 20 Pha rmaceutical % 20 Sciences; PID=2018-8-4-13
2. https://ajpsonline.com/HTML Paper.aspx? Journal = Asian % 20 Journal % 20 of % 20 Research % 20 in % 20 Pharmaceutical % 20 Sciences; PID=2018-8-4-13
3. https://www.researchgate.net/publication/291053675_Awareness_About_Banned_Drugs_A_Review
4. https://www.linkedin.com/pulse/awareness banned-drugs-india-gaurav–kumar-sharma
5. https://rjpdft.com/HTMLPaper.aspx ? Journal = Research % 20 Journal %20 of % 20 Pharmaceutical % 20 Dosage % 20 Forms % 20 and % 20Technology; PID=2019-11- 2-6
6. https://www.jcdr.net/article_fulltext.asp?id=349
7. Kiran Kabtta Somyanshi. Drugs banned abroad may still be use in some cases. The Economic Times.www.articles.economictimes.indiatimes.com/20130107/news/36192943_1_cdsco_drugs_standard_control_organization_side_effects.
8. Medic8. Nimesulide side effects online. 2010 Nov.5; Available From URL; http//www.ethow.com/facts_7312477_nimesulide_banned_html.
9. Tripathi KD. Essentials of medical pharmacology. New Delhi: Jaypee Brother Medical Publisher (P) Ltd; 1997.
10. Kernan WN, Viscoli CM, Brass LM. Phenylpropanolamine and the risk of hammorhagic stroke. N. Engl. J. Med. 2000; 343(25):1826-32.
11. Nutt D, King LA, Saulsbury W, Blakemore C. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet. 2007; 369(9566):1047-53.
12. John J. Donohue lll, Rethinking Amerika’s illegal drupolicy.www.ycsg.yale.edu/center/forms/ US-illegal drug policy-145-158.
13. http://enn.wikipedia.org/wiki/prohibition of drugs.
14. https://www.ijirt.org/Article?manuscript=152435
15. Gulhati CM. government commission ident useless, hazardous, irrational drugs. Monthly in of Medical Specialities, India Nov2005.
16. https://www.researchgate.net/publication/275653400_Awareness_about_Banned_Drugs_A_Matter _of_Concern.

Published

2023-12-15

How to Cite

Vaishnavi S, G., Sachin, H., Priyanka D, Y., Mohini A, G., Ayesha N, S., Madhav, H., … Madhuri., P. (2023). A Review on Banned Drugs. Asian Journal of Pharmaceutical Research and Development, 11(6), 31–35. https://doi.org/10.22270/ajprd.v11i6.1331

Most read articles by the same author(s)